Search results
Appearance
- ...Brigham and Women's Hospital, pioneering genomic research that identifies BAP1, CDKN2A, and other critical mutations. ...Raphael Bueno, International Mesothelioma Program, mesothelioma genomics, BAP1 mutation, CDKN2A, Brigham and Women's Hospital, personalized medicine ...24 KB (3,099 words) - 04:00, 9 March 2026
- ...prognosis covering validated scoring systems (EORTC, CALGB, Brims, PLECH), BAP1 mutations, blood biomarkers, and factors that improve individual outcomes. ...prognosis, prognostic factors mesothelioma, mesothelioma scoring systems, BAP1 mesothelioma, mesothelioma long-term survival, PLECH score, mesothelioma li ...41 KB (5,121 words) - 20:56, 8 March 2026
- |title=Mesothelioma Molecular and Genetic Testing: BAP1, CDKN2A, NGS Panels & Biomarker-Guided Treatment ...ehensive guide to molecular and genetic testing for mesothelioma including BAP1 mutations, CDKN2A FISH, NF2 inactivation, next-generation sequencing panels ...55 KB (7,206 words) - 22:37, 8 March 2026
- == What Role Do BAP1, TMB, and Other Biomarkers Play? == === BAP1 Mutations === ...36 KB (4,570 words) - 09:56, 6 April 2026
- ...le patients with secondary (paraoccupational) exposure, a greater role for BAP1 germline mutations, and incomplete occupational histories. ...carcinoma include BerEP4, CEA, and TTF-1.<ref name="pmc5674249" /> Loss of BAP1 nuclear expression is highly specific for distinguishing malignant from ben ...30 KB (3,699 words) - 01:11, 6 April 2026
- ...oma, calretinin, mesothelioma misdiagnosis, PET CT mesothelioma, MESOMARK, BAP1, epithelioid mesothelioma, sarcomatoid mesothelioma, peritoneal cancer inde ...age groupings.<ref name="jtd_staging" /> Emerging molecular testing for '''BAP1''', '''CDKN2A''', and other genetic alterations is increasingly important f ...58 KB (7,640 words) - 09:56, 6 April 2026
- ...vs peritoneal differences, biological mechanisms, genetic predisposition (BAP1/RAD51), and courtroom implications for statute of limitations. ...neal mesothelioma latency, mesothelioma in situ, pleural plaques timeline, BAP1 mutation, RAD51 mutation, mesothelioma diagnosis gap ...53 KB (7,014 words) - 22:37, 8 March 2026
- ...-meso" /> Current research into CAR-T cell therapy, gene therapy targeting BAP1 mutations, and novel immunotherapy combinations continues to push the bound ...d precision medicine''' — The discovery that 44-60% of mesotheliomas carry BAP1 mutations opened the door to gene therapy and targeted treatment strategies ...38 KB (4,755 words) - 03:42, 9 March 2026
- * '''BAP1 mutation paradox''' — Patients with this genetic alteration survive 5x long ...ive biomarkers for immunotherapy response. Patients with triple mutations (BAP1/CDKN2A/CDKN2B) plus PD-L1 positivity achieved median survival of 15.8 month ...37 KB (4,489 words) - 20:45, 17 March 2026
- ...oracentesis mesothelioma, pleural biopsy accuracy, IHC panel mesothelioma, BAP1 biopsy, CDKN2A FISH biopsy ...ardized marker panels, conducting ancillary molecular testing including '''BAP1 loss''' and '''CDKN2A FISH''', and developing an evidence-based treatment p ...60 KB (7,892 words) - 10:12, 6 April 2026
- ...Sterman, mesothelioma clinical trials, tumor suppressor gene replacement, BAP1 mesothelioma, CRISPR mesothelioma * BAP1 is the most commonly mutated gene in mesothelioma (~60% of cases), and its ...67 KB (8,763 words) - 09:18, 6 April 2026
- ...tients — covering diagnostic fluid analysis, cytology sensitivity (45.1%), BAP1/MTAP biomarkers, ultrasound guidance, complications, IPC vs pleurodesis com ...ral effusion drainage, malignant pleural effusion, pleural fluid cytology, BAP1 immunohistochemistry, MTAP mesothelioma, ultrasound guided thoracentesis, i ...69 KB (8,827 words) - 10:21, 6 April 2026
- ...non-asbestos causes—including erionite, radiation, genetic predisposition (BAP1 mutations), carbon nanotubes, and spontaneous mesothelial transformation—in === BAP1 Tumor Predisposition Syndrome === ...42 KB (5,297 words) - 01:11, 6 April 2026
- ...0px; border-bottom:1px solid #dee2e6;" | Recurrent inactivation of CDKN2A, BAP1, NF2, and TP53 tumor suppressors, matching pleural mesothelioma patterns (S ...n asbestos-related pleural mesothelioma — including alterations in CDKN2A, BAP1, NF2, and TP53 — are also present in pericardial mesothelioma. This shared ...56 KB (6,937 words) - 09:57, 6 April 2026
- ...with the immunohistochemistry panels — calretinin, WT-1, D2-40, claudin-4, BAP1, and MTAP — required to distinguish mesothelioma from its imitators.<ref na ...tivity and 94–100% specificity for carcinoma versus mesothelioma). Loss of BAP1 nuclear staining and MTAP deletion by FISH are additional discriminators fo ...39 KB (5,209 words) - 16:36, 6 April 2026
- ...diagnosed cases; remaining cases linked to erionite, radiation therapy, or BAP1 gene mutations<ref name="dandell-exposure" /><ref name="mesonet-causes" /> ...r and may qualify for targeted therapies<ref name="asco-2025" /><ref name="bap1-germline" /> ...62 KB (7,831 words) - 01:11, 6 April 2026
- * '''BAP1 Research:''' Collaborative research on germline mutations in mesothelioma f ...He has also contributed to European mesothelioma treatment guidelines and BAP1 genetic susceptibility research. ...27 KB (3,530 words) - 04:00, 9 March 2026
- | style="padding:10px; border-bottom:1px solid #dee2e6;" | '''BAP1 Loss as Diagnostic Marker''' | style="padding:10px; border-bottom:1px solid #dee2e6;" | BAP1 expression loss detected by IHC in approximately 60–70% of epithelioid meso ...59 KB (7,425 words) - 01:11, 6 April 2026
- ...n-Targeted Therapies:''' New therapies designed for patients with germline BAP1 mutations, which confer mesothelioma predisposition. ...Mesothelioma Treatment Advances (2025): CAR-T, CRISPR, viral gene therapy, BAP1-targeted therapies, TTFields, combination immunotherapy + gene therapy. Mes ...43 KB (5,354 words) - 03:51, 9 March 2026
- ...for immunohistochemistry panels — including calretinin, WT1, D2-40, CK5/6, BAP1, and CDKN2A — and VATS provides tissue specimens far superior in both quant ...carcinoma markers (TTF-1, CEA, Ber-EP4, claudin-4). Additionally, loss of BAP1 expression and homozygous deletion of CDKN2A (p16) detected by FISH are inc ...60 KB (7,800 words) - 22:21, 8 March 2026